DermaSensor Empowers Internists to Diagnose Skin Cancer: What Will This Mean for Derms and Patients?
The U.S Food and Drug Administration (FDA) has cleared DermaSensor for skin cancer detection in primary care, the Company reports. Wireless and handheld, DermaSensor’s AI-powered spectroscopy technology non-invasively evaluates cellular and subcellular characteristics of a lesion, providing an immediate and objective result using an FDA-cleared algorithm. The FDA pivotal study of more than 1,000 patients, showed […]